Merck reports additional positive data for Keytruda in NSCLC
Merck’s Keytruda shows improvements in non-small cell lung cancer patients. Credit: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more